IBD-5010
Completed
A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)
Clinicaltrials.gov
#NCT04873700About this clinical trial
The main aim of this study is to check the disease activity in people with moderate to severe ulcerative colitis and Crohn's disease. Participants will complete questionnaires about their disease and quality of life on Day 1 clinic visit. They will do this during a standard scheduled appointment with their doctor. Some of this study will also involve collecting information about participants from their medical records.
MX
Observational clinical trial.
At a glance
What medical conditions were being studied?
Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease (IBD)
How many participants were enrolled?
335
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Aug 2021 - May 2022
How long was participation in the clinical trial?
Participants will be in the study for one day.
Key requirements
Sex
All
Age
18+ years
Healthy volunteers?
No
Entry criteria
Both men and women can take part.
Must be an adult, 18 years or older.
Must have had moderate to severe Ulcerative Colitis or Crohn’s Disease for at least 6 months.
Cannot have indeterminate or unclassified colitis.
